Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
Aptar Pharma Announces Development & License Agreement With BD September 2, 2016
Aptar Pharma Announces Development & License Agreement With BD Aptar Pharma, a leading drug delivery solutions provider...SOFTGEL FORMULATIONS - Lipid-Based Drug Delivery System to Bring Poorly Soluble Drugs to Market August 30, 2016
Ronak Savla, PhD, PharmD, and Jeffrey E. Browne, PhD, indicate formulation screening, development, scale-up, and commercial manufacture of LBDDSs require considerable expertise, and choosing an outsourcing partner with experience and a proven track record is critical.
ORALLY DISINTEGRATING TABLETS - Designed With Patients in Mind: The Art of Patient-Centric Drug Formulation August 30, 2016
Anthony Recupero, PhD, believes by partnering with an expert in drug delivery technology, whose portfolio features a broad range of proprietary technologies, pharmaceutical companies have the potential to add further value to their products and extend market exclusivity.
DELIVERY PLATFORM - Encochleated Drug Formulations: Enhancing Efficacy, Minimizing Toxicity June 30, 2016
Roelof Rongen, MBA, MS, indicates drugs for serious fungal and microbial infections currently require IV administration at doses associated with significant toxicity. Orally administered, encochleated formulations of a broad-spectrum of fungicidal and anti-microbial medications may provide delivery of anti-infective drugs at therapeutic levels while minimizing drug-associated side effects.
GLOBAL FORMULATION REPORT - Notable Technologies, Approvals, Transactions, Pipelines & Inflection Points June 30, 2016
This Global Formulation Report is a joint initiative by Drug Development & Delivery and PharmaCircle LLC, covering several areas of significant interest in today’s ever-challenging pharmaceutical and biotechnology industries.
MICROBIAL PRODUCTION - Cutting-Edge inABLE® Technology: The Key to Cost-Effective Production of a Novel Antimicrobial Peptide With Potential for the Treatment of MRSA June 1, 2016
Ian Fotheringham, PhD, and Mathew Upton, PhD, report that Infections caused by antibiotic resistant bacteria are an ever-increasing threat to public health, creating an urgent, growing demand for the identification and development of new therapies.
Hebei Changshan Biochem Pharma & Albumedix Enter Development Agreement May 20, 2016
Albumedix and Hebei Changshan Biochem Pharma Co. recently announced they have entered into a supply agreement for the development of...Patheon Selected by Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology April 25, 2016
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with...Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology April 19, 2016
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement...Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics February 16, 2016
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The...NANOSCALE COMPLEXES - A Novel Nanotechnology-Based Platform to Optimize Combination Cancer Therapies: Rational Development & Improved Delivery Using CombiPlex® January 7, 2016
Barry D. Liboiron, PhD; Arthur C. Louie, MD; et al describe how CombiPlex addresses the challenges facing the traditional development path of many contemporary drug combinations and provide clinical proof-of-principle evidence that this approach can yield marked improvements in efficacy and patient outcomes.
Ashland Aids Pharmaceutical Manufacturers With Formulation Services December 8, 2015
Pharmaceutical scientists at Ashland understand how polymers interact with complex drug molecules. These experts presented at CPhI India to explain...ADVANCED DELIVERY DEVICES - Implantable Drug-Eluting Devices: A Novel Approach to Patient Care October 6, 2015
Samuel D. Trohman, MBA, Joey L. Glassco, Elena Draganoiu, PhD, and Carey Boyum present developmental and commercial examples of non-biodegradable drug-eluting devices, along with the versatile properties of thermoplastic polyurethanes for the development of effective drug delivery systems.
Glenmark Pharmaceuticals' Novel Monoclonal Antibody to Enter Phase II September 8, 2015
Glenmark Pharmaceuticals S.A. recently announced that GBR 830, a novel monoclonal antibody has completed clinical Phase I dosing. GBR 830...HOT MELT EXTRUSION - OptiMelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs August 31, 2015
Sampada Upadhye, PhD, indicates bioavailability enhancement with formulation and dose form flexibility can be achieved through the application of HME technology to produce stable drug formulations and increased development success rates.
DNA VACCINE TECHNOLOGY - A Vaccine Breakthrough That Could Change Lives & Enable Vaccine Development Programs August 31, 2015
William Hearl, PhD, asks what if there was the potential for a better and safer treatment for allergies, a less-toxic cancer therapy, or a breakthrough treatment to improve the health of a pet or valuable livestock? What if you could employ a new, patented technology that may make these treatments possible?
Enteris Biopharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' Peptide August 25, 2015
Enteris BioPharma, Inc. congratulates Cara Therapeutics on the dosing of the first patients in a Phase II trial of an...Catalent's Proprietary Softgel Technology Used to Provide Daily Dosing of Modified-Release Semi-Solid Formulation August 10, 2015
Catalent Pharma Solutions recently welcomed the announcement by OPKO Health that the US Food and Drug Administration has accepted for...Immune Pharmaceuticals Expands Immuno-Dermatology Development Portfolio June 12, 2015
Immune Pharmaceuticals Inc. recently announced it has entered into a binding Memorandum of Understanding with Yissum, the Technology Transfer Company...FORMULATION DEVELOPMENT - Overcoming Early Phase Development Challenges & Optimizing Formulations With a Minimal Amount of API June 2, 2015
ABSTRACT Softgel is a proven and effective delivery technology for poorly soluble drugs and can incorporate a wide range of...Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products
Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.
